

Exorenal
xKidney – Novel Portable & Home Hemodialysis System
Chronic kidney failure patients are steeply increasing worldwide. In-center hemodialysis (HD) has become the standard treatment, but this has raised many problems. Most patients suffer from harsh dietary restrictions and severe complications, resulting in an unacceptably high rate of mortality: ~50% over 5 years. Due to the dialysis schedules (3 times a week), travel arrangements and participation in social activities…Read More
Longeviti
Pioneering Innovative Solutions for Complex Brain Surgery
Longeviti’s mission is to develop innovative solutions for complex brain surgery that return patients to anatomical normalcy.
Novel Microdevices
Manufacturing Innovative Diagnostic Products for Enhancing Patient Healthcare
Novel Microdevices is commercializing Novel Dx, a proprietary and best-in-class Point-of-Care (POC) rapid molecular diagnostics system that is designed to be CLIA-waived. The Novel Dx system includes an ultra-portable instrument and test-specific consumable cartridges that can be produced for a wide range of high-volume molecular diagnostic assay applications. The company is focusing on the $31 Billion Infectious Diseases Diagnostics Market with tests in development for multiple respiratory and sexually transmitted infections.
Lifesprout
Revolutionary Products for Tissue Replacement and Regeneration
LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The company’s Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the body’s own tissues. LifeSprout is turning this technology into a suite of products for the millions of patients with tissue losses from aging, cancer, metabolic disease, and orphan indications. The company’s lead product Lumina™ is a breakthrough family of aesthetic fillers enabling immediate, natural restoration with biostimulatory effects. LifeSprout’s next generation cell therapy products use the power of the platform to promote true tissue regeneration.
Coaptech
Ultrasound Gastrostomy is Here
CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive technology called Coaptive Ultrasound which is owned by the company. CoapTech devices will reduce health care costs, and improve safety, quality, patient experience, and access to services around the globe.
Vixiar
Point of Care, Non-invasive, Cost Effective Monitoring for Heart Failure
Vixiar Medical has developed a non-invasive, hand-held device and software platform, for assessing congestion to detect worsening heart failure. The Company’s Indicor™ device is for point-of-care use in hospitals, physician’s offices and patient homes and is an alternative to less accurate, more expensive, and invasive approaches. Indicor is the only true point-of-care, and remote monitoring device for detecting changes in intrathoracic fluid volume. The test takes under 3 minutes to perform and is spun out of John’s Hopkins
EyeDea
Alleviating the global burden of corneal blindness through innovative solutions in eye banking and corneal transplantation
Eyedea Medical is an early-stage, women-owned, ophthalmic medical device company working to reduce the burden of corneal blindness globally through development of novel medical devices to improve outcomes and access to vision-restoring corneal procedures. Our first product, DescePrep, is a DMEK preparation device that standardizes and improves the efficiency.
CoolTech Medical
Targeted Temperature Management
The CoolStat – a completely new way to manage patient temperature – designed to provide effective cooling that is simple, safe and easy-to-use.
Lifejoint Orthopedic Solutions
Finger Joint Implant Device
More than 20 million people in the US have symptomatic hand arthritis. Six million are actively seeking treatment to relieve pain and preserve motion.
The majority are excluded from electing joint replacement surgery (arthroplasty) because of active lifestyle demands or inadequate stabilizing tissue in their finger joints. High risk and unpredictable outcomes for current devices leave an estimated 1.2 million advanced stage arthritis patients with no good treatment options.
Lifejoint was founded by a hand trauma patient and surgeon to answer this underserved market. We are developing a new small joint replacement technology that promises to relieve pain and preserve motion for osteoarthritis, rheumatoid arthritis, and post-traumatic hand arthritis patients.
Sonogen
Advanced Ultrasound Bone Fracture Healing
Sonogen was established to research, develop, and commercialize our next-generation ultrasonic bone fracture healing technology.
Cutting Edge Science
Sonogen has combined decades of experience in fluid mechanics and biophysics with extensive experience in sonar and medical ultrasound to develop the next generation of safe and effective ultrasound-based bone fracture healing devices.
Validated Technology
Sonogen’s innovative multi-modal ultrasonic bone fracture stimulation technology has been shown to be extremely effective for bone growth stimulation in recent animal trials conducted with two of the world’s most well-respected medical institutions.
June Brain, Inc.
Changing the Future of Neurology and Eye Care
JuneBrain was founded to improve remote assessments and monitoring of neurological and retinal diseases. We provide telehealth devices and AI software solutions. Our products are user-friendly, portable, and adaptable for clinical and point-of-care settings. Our vision is to improve health outcomes for individuals with eye and brain diseases by expanding access to healthcare across the globe.
Nanochon
Advanced Orthopedic Care
Nanochon is advancing orthopedic care with an innovative implant designed for “pre-replacement” patients — those with cartilage damage who need more than temporary relief but aren’t yet candidates for joint replacement.
Nanochon is a clinical-stage medical device company focused on developing innovative orthopedic solutions to repair cartilage for active patients with cartilage damage. Our patented, 3D printed solution, Chondrograft, is a bone-sparing, fully synthetic, off-the-shelf, press-fit implant that mimics natural cartilage and provides immediate mechanical support. Its structure disburses the load, promotes hyaline-like cartilage, and fosters the restoration of both cartilage and subchondral bone.
Arenal Medical Corp
Revolutionizing the detection of peripheral arterial disease (PAD)
Arenal Medical is a pioneering digital health company focused on bringing cardiovascular care into the 21st century by proactively detecting Peripheral Artery Disease (PAD). The company utilizes a proprietary ecosystem of wireless Doppler ultrasound sensors to deliver gold-standard diagnostic testing directly at the point of care. The intuitive platform produces highly accurate cardiovascular reports in under ten minutes and seamlessly integrates with modern electronic medical record (EMR) systems. By replacing outdated, complex testing methods with accessible, efficient technology, Arenal Medical empowers providers to prevent critical cardiovascular events before they occur.
Somnair
Non-invasive neurostimulation oral appliance therapy for obstructive sleep apnea
Somnair is a medical device startup developing an innovative non-invasive neurostimulation oral appliance therapy for obstructive sleep apnea (OSA). The company is focused on creating a patient-friendly solution designed to improve airway patency during sleep without the burden of traditional CPAP therapy or surgery. By combining clinical insight with advanced engineering, Somnair aims to expand access to effective treatment for the 1 billion people globally suffering from OSA.

Kubanda Cryotherapy
Helping pets and vets skip the scalpel with cryotherapy
Kubanda is disrupting the $4B global veterinary tumor market by providing a point-of-care, minimally invasive, low-cost treatment via carbon dioxide-based cryotherapy. The technology has been validated in veterinary clinical trials and is in use in dozens of clinics across North America.
Vectech
AI Entomology
Vectech is a public benefit corporation based in Baltimore, MD building solutions that support pest control organizations in their mission to end vector-borne diseases, agriculture loss, and economic loss caused by Pests.
Previse
Biomarker technology for detection of esophageal cancer
At Previse, we are developing precision medicine solutions aimed at prevention and earlier detection of cancer, starting with esophageal cancer. Our solutions are built upon a foundation of proprietary epigenetic biomarkers and strong data science to support diverse clinical study populations around the world.
SpeechVive
Communications therapy for Parkinson’s
SpeechVive’s mission is to improve the quality of communication for people with Parkinson’s disease by empowering care partners and clinicians with technologies and support to restore one’s ability to communicate.
eNeura
Central neuromodulation therapy for migraine management
SAVI Dual is the only clinically effective central neuromodulation therapy developed to treat acute attacks and prevent future migraine days. This patented dual migraine therapy directly targets and signals the brain to quiet the hyperactive nerves thought to be the source of migraine.




























